Adonis Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 17-07-2024
- Paid Up Capital ₹ 0.10 M
as on 17-07-2024
- Company Age 13 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.00 M
as on 17-07-2024
- Satisfied Charges ₹ 1.10 Cr
as on 17-07-2024
- Revenue -23.93%
(FY 2023)
- Profit -54.55%
(FY 2023)
- Ebitda -23.68%
(FY 2023)
- Net Worth 10.01%
(FY 2023)
- Total Assets -20.94%
(FY 2023)
About Adonis Biotech
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.00 M. The company has closed loans amounting to ₹1.10 Cr, as per Ministry of Corporate Affairs (MCA) records.
Pushpendra Rawat and Rajrani Sharma serve as directors at the Company.
- CIN/LLPIN
U24232RJ2011PTC036690
- Company No.
036690
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Oct 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Adonis Biotech Private Limited offer?
Adonis Biotech Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, Biochemistry Analyzer, Optical Components, Optical Filters, Clinical Reagents, Hematology Reagents, Hematology Analyzers, Cell Counter, Street, Flood and Commercial Lights, Halogen Lamps.
Who are the key members and board of directors at Adonis Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pushpendra Rawat  | Director | 12-Oct-2011 | Current |
| Rajrani Sharma | Director | 12-Oct-2011 | Current |
Financial Performance of Adonis Biotech.
Adonis Biotech Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 23.93% decrease. The company also saw a substantial fall in profitability, with a 54.55% decrease in profit. The company's net worth Soared by an impressive increase of 10.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Adonis Biotech?
In 2023, Adonis Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 23 Mar 2022 | ₹2.00 M | Open |
Idbi Bank Limited Creation Date: 29 Dec 2021 | ₹4.00 M | Satisfied |
Idbi Bank Limited Creation Date: 04 Mar 2019 | ₹2.50 M | Satisfied |
How Many Employees Work at Adonis Biotech?
Unlock and access historical data on people associated with Adonis Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Adonis Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adonis Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
